Core Viewpoint - Myp Medical is expanding its presence in the neuro-interventional medical supplies sector by acquiring 100% of Guangzhou Yijie Medical Technology Co., Ltd. for 335 million yuan, marking a significant step towards establishing a comprehensive solution for neurology departments [2][3]. Financial Performance - In the first half of 2025, Myp Medical achieved revenue of 158 million yuan, a year-on-year increase of 29.28%, and a net profit of 47.3 million yuan, up 46.03% [2][6]. - The company reported a gross margin of 80.59% in the first half of 2025, an increase of 1.74 percentage points compared to the same period last year [6][7]. - From 2019 to 2023, the compound annual growth rate (CAGR) of net profit was 10%, with a notable acceleration in 2024, where revenue reached 278 million yuan, a 20.61% increase year-on-year [6][7]. Research and Development - Myp Medical's R&D investment reached 19.29 million yuan in the first half of 2025, a significant increase of 58.95% year-on-year, with total R&D expenditure from 2020 to the first half of 2025 amounting to 206 million yuan [6][7][8]. - The company holds 259 domestic patents and 30 international patents, with 178 of them being invention patents [8]. Acquisition Details - The acquisition of Yijie Medical will be financed through a combination of share issuance and cash payment, with the transaction price determined through negotiations involving third-party evaluators to ensure fairness [3][4]. - Yijie Medical specializes in neuro-interventional products, having established a product line that includes key devices such as neuro-interventional catheters and guidewires, which are already approved for sale in over 200 top-tier hospitals [3][4]. Strategic Implications - The acquisition is expected to enhance Myp Medical's market competitiveness in neurology by integrating its product lines and leveraging technological and channel synergies, thereby accelerating the domestic substitution of high-value medical supplies [5].
迈普医学3.35亿收购易介医疗扩版图 五年半研发投入2.06亿筑牢创新根基